These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

332 related items for PubMed ID: 10063999

  • 1. Inhibitor antibody development and T cell response to human factor VIII in murine hemophilia A.
    Qian J, Borovok M, Bi L, Kazazian HH, Hoyer LW.
    Thromb Haemost; 1999 Feb; 81(2):240-4. PubMed ID: 10063999
    [Abstract] [Full Text] [Related]

  • 2. Characterization of the immune response to factor VIII using hemophilia A* mice.
    Hoyer LW, Qian J.
    Haematologica; 2000 Oct; 85(10 Suppl):100-2. PubMed ID: 11187859
    [Abstract] [Full Text] [Related]

  • 3. Single cell analysis of factor VIII-specific T cells in hemophilic mice after treatment with human factor VIII.
    Sasgary M, Ahmad RU, Schwarz HP, Turecek PL, Reipert BM.
    Thromb Haemost; 2002 Feb; 87(2):266-72. PubMed ID: 11858486
    [Abstract] [Full Text] [Related]

  • 4. Blockade of CD40/CD40 ligand interactions prevents induction of factor VIII inhibitors in hemophilic mice but does not induce lasting immune tolerance.
    Reipert BM, Sasgary M, Ahmad RU, Auer W, Turecek PL, Schwarz HP.
    Thromb Haemost; 2001 Dec; 86(6):1345-52. PubMed ID: 11776297
    [Abstract] [Full Text] [Related]

  • 5. Heterogeneity of the immune response to adenovirus-mediated factor VIII gene therapy in different inbred hemophilic mouse strains.
    Rawle FE, Shi CX, Brown B, McKinven A, Tinlin S, Graham FL, Hough C, Lillicrap D.
    J Gene Med; 2004 Dec; 6(12):1358-68. PubMed ID: 15493040
    [Abstract] [Full Text] [Related]

  • 6. Role of CD154 in the secondary immune response: the reduction of pre-existing splenic germinal centers and anti-factor VIII inhibitor titer.
    Qian J, Burkly LC, Smith EP, Ferrant JL, Hoyer LW, Scott DW, Haudenschild CC.
    Eur J Immunol; 2000 Sep; 30(9):2548-54. PubMed ID: 11009088
    [Abstract] [Full Text] [Related]

  • 7. Characterization of antibodies induced by human factor VIII in a murine knockout model of hemophilia A.
    Reipert BM, Ahmad RU, Turecek PL, Schwarz HP.
    Thromb Haemost; 2000 Nov; 84(5):826-32. PubMed ID: 11127864
    [Abstract] [Full Text] [Related]

  • 8. Long-term persistence of anti-factor VIII antibody-secreting cells in hemophilic mice after treatment with human factor VIII.
    Hausl C, Maier E, Schwarz HP, Ahmad RU, Turecek PL, Dorner F, Reipert BM.
    Thromb Haemost; 2002 May; 87(5):840-5. PubMed ID: 12038787
    [Abstract] [Full Text] [Related]

  • 9. T lymphocyte proliferative responses induced by recombinant factor VIII in hemophilia A patients with inhibitors.
    Singer ST, Addiego JE, Reason DC, Lucas AH.
    Thromb Haemost; 1996 Jul; 76(1):17-22. PubMed ID: 8819245
    [Abstract] [Full Text] [Related]

  • 10. Mechanism of the immune response to human factor VIII in murine hemophilia A.
    Wu H, Reding M, Qian J, Okita DK, Parker E, Lollar P, Hoyer LW, Conti-Fine BM.
    Thromb Haemost; 2001 Jan; 85(1):125-33. PubMed ID: 11204564
    [Abstract] [Full Text] [Related]

  • 11. Hemophilia factor VIII therapy. Immunological tolerance. A clinical perspective.
    White GC, Greenwood R, Escobar M, Frelinger JA.
    Haematologica; 2000 Oct; 85(10 Suppl):113-6. PubMed ID: 11187862
    [Abstract] [Full Text] [Related]

  • 12. Hemophilia. Strategies for the treatment of inhibitor patients.
    Ingerslev J.
    Haematologica; 2000 Oct; 85(10 Suppl):15-20. PubMed ID: 11187863
    [Abstract] [Full Text] [Related]

  • 13. Correlation between factor VIII genotype and inhibitor development in hemophilia A.
    Fakharzadeh SS, Kazazian HH.
    Semin Thromb Hemost; 2000 Oct; 26(2):167-71. PubMed ID: 10919409
    [Abstract] [Full Text] [Related]

  • 14. Antibodies to factor VIII in hemophilia A patients.
    Brackmann HH, Schwaab R, Effenberger W, Hess L, Hanfland P, Oldenburg J.
    Vox Sang; 2000 Oct; 78 Suppl 2():187-90. PubMed ID: 10938950
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Identification of a novel immunodominant cytotoxic T lymphocyte epitope derived from human factor VIII in a murine model of hemophilia A.
    Wang W, Merchlinsky M, Inman J, Golding B.
    Thromb Res; 2005 Oct; 116(4):335-44. PubMed ID: 16038719
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Inhibitors to factor VIII in a family with mild hemophilia: molecular characterization and response to factor VIII and desmopressin.
    Santagostino E, Gringeri A, Tagliavacca L, Mannucci PM.
    Thromb Haemost; 1995 Aug; 74(2):619-21. PubMed ID: 8584995
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Factor VIII inhibitors: role of von Willebrand factor on the uptake of factor VIII by dendritic cells.
    Kaveri SV, Dasgupta S, Andre S, Navarrete AM, Repessé Y, Wootla B, Lacroix-Desmazes S.
    Haemophilia; 2007 Dec; 13 Suppl 5():61-4. PubMed ID: 18078399
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.